Achieving Supply Chain Resiliency Amid Geopolitical Risk

Does Your Company Have All the Bases Covered? 

Employing effective strategies to assess and mitigate risk is crucial to building resiliency in supply chains. In an ever-changing global landscape, this becomes even more challenging where geopolitical and other unforeseen events come into play.   

Gain valuable insights from an executive panel—from within and outside the industry—who will share best practices and lessons learned on how to prepare, monitor, and respond to potential or actual disruption due to geopolitical events and other macro environmental factors.  

Gain perspectives on these all-important questions:  

• What risks arise from geopolitical factors and how can such risks can be monitored? 
• What risk-mitigation practices should be in place? 
• How should customers and suppliers plan for response to disruption due to geopolitical and macro environmental factors? When is joint scenario planning appropriate? 
• How can joint implementation of risk mitigation be best executed? 

Panelists

• Lisa Martin, Senior Vice President and Chief Procurement Officer, GSK
• Sally Macaluso, Chief Procurement Officer,  GE HealthCare
• Alejandro Fernandez, Director, Product Planning & Fulfillment, Cisco
• Carla La Montagna, Senior Sourcing Director, Biologics and Packaging, Johnson & Johnson
• Moderator: Derron Stark, EY-Parthenon Partner, Strategy & Transactions – Life Sciences, Supply Chain, Ernst & Young LLP

Price & Registration

DCAT Member Company Price: $99 

DCAT Week 2025 programs are exclusively available to registered DCAT Member Company employees. Confirm your company’s membership here or email DCATMembership@dcat.org.

Who Should Attend?

• Bio/pharmaceutical companies, including individuals with functional responsibility in sourcing, procurement, supply management and external manufacturing.
• CDMOs/CMOs and suppliers (raw materials and other inputs), including individuals engaged in business development, sales, marketing and operational functions in support of bio/pharmaceutical development and manufacturing.
• Other companies engaged in the business of bio/pharmaceutical development and manufacturing.

Attending DCAT Week Programs

All materials provided to registrants (including slides, reports, and presented information) are only for their reference. Registrants may not copy, photograph, or redistribute any materials, and they are responsible for any claim for violations of copyright or other intellectual property rights.